Christophe Corpechot

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Ulcerative Colitis

Magnetic Resonance

Electronic Health Record

Top Venues

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

Journal of medical virology

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

This page only lists publications with an associated author ORCID identifier.

Publications

Christophe Corpechot, Marie Verdoux, Marie Frank-Soltysiak, Jean-Charles Duclos-Vallée, Lamiae Grimaldi
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting. Journal of medical virology 96 (1) (2024)
Aldo J Montano-Loza, Christophe Corpechot, Patrizia Burra, Christoph Schramm, Gonzalo Sapisochin, Vincenzo Ronca, Ye Htun Oo
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024)
Christophe Corpechot, Marie Verdoux, Marie Frank-Soltysiak, Jean-Charles Duclos-Vallée, Lamiae Grimaldi
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting. Journal of medical virology 96 (1) (2024)
Christophe Corpechot, Marie Verdoux, Marie Frank-Soltysiak, Jean-Charles Duclos-Vallée, Lamiae Grimaldi
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting. Journal of medical virology 96 (1) (2024)
Christophe Corpechot, Sara Lemoinne, Pierre-Antoine Soret, Olivier Chazouillères, Victor de Lédinghen
Reply: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. Hepatology (Baltimore, Md.) 79 (5) (2023)
Christophe Corpechot, Sara Lemoinne, Pierre-Antoine Soret, Olivier Chazouillères, Victor de Lédinghen
Reply: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. Hepatology (Baltimore, Md.) 79 (5) (2023)
Christophe Corpechot, Sara Lemoinne, Pierre-Antoine Soret, Olivier Chazouillères, Victor de Lédinghen
Reply: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Gideon M Hirschfield, Mitchell L Shiffman, Gideon M Hirschfield, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, Christopher L Bowlus, Eric J Lawitz, Richard J Aspinall, Daniel S Pratt, Karina Raikhelson, Maria S Gonzalez-Huezo, Michael A Heneghan, Sook-Hyang Jeong, Alma L Ladrón de Guevara, Marlyn J Mayo, Georgios N Dalekos, Joost Paulus Hubertus Drenth, Ewa Janczewska, Barbara A Leggett, Frederik Nevens, Víctor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Invernizzi Pietro, Palak J Trivedi, Lisa Forman, David E J Jones, Stephen D Ryder, Mark G Swain, Alexandra Steinberg, Pol F Boudes, Yun-Jung Choi, Charles A McWherter, null null
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.) (2023)
Pierre-Antoine Soret, Sara Lemoinne, Maxime Mallet, Karima Ben Belkacem, Olivier Chazouillères, Christophe Corpechot
Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndrome. Alimentary pharmacology & therapeutics (2023)
Pierre-Antoine Soret, Laurent Lam, Fabrice Carrat, Lena Smets, Thomas Berg, Marco Carbone, Invernizzi Pietro, Vincent Leroy, Palak Trivedi, Nora Cazzagon, Christina Weiler-Normann, Laurent Alric, Isabelle Rosa-Hezode, Alexandra Heurgué, Jean-Paul Cervoni, Jérôme Dumortier, Pascal Potier, Olivier Roux, Christine Silvain, Christophe Bureau, Rodolphe Anty, Dominique Larrey, Cynthia Levy, Albert Pares, Christoph Schramm, Frederik Nevens, Olivier Chazouillères, Christophe Corpechot
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis. Alimentary pharmacology & therapeutics 53 (10) (2021)
Sara Lemoinne, Nora Cazzagon, Olivier Chazouillères, Christophe Corpechot, Lionel Arrivé
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC. Alimentary pharmacology & therapeutics 53 (12) (2021)
Christophe Corpechot, Olivier Chazouillères, Sara Lemoinne, Alexandra Rousseau
Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA response. Alimentary pharmacology & therapeutics 49 (2) (2019)
Fiorella Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, Annarosa Floreani, Marlyn J Mayo, Adriaan van der Meer, Cyriel Y Ponsioen, Willem J Lammers, Albert Parés, Invernizzi Pietro, Marco Carbone, Pier Maria Battezzati, Frederik Nevens, Kris V Kowdley, Douglas Thorburn, Andrew L Mason, Palak J Trivedi, Keith D Lindor, Tony Bruns, George N Dalekos, Nikolaos K Gatselis, Xavier Verhelst, Harry L A Janssen, Bettina E Hansen, Aliya Gulamhusein, null null
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response. Alimentary pharmacology & therapeutics 50 (10) (2019)